Aomics (Drug Discovery) Overview
- Year Founded
-
2015

- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Aomics (Drug Discovery) General Information
Description
Developer of an anti-cancer drug based in Carlsbad, United States. The company develops drugs by fusing an antibody to the paclitaxel molecule, enabling patients to cure themselves and be healthy and safe.
Contact Information
Corporate Office
- 6076 Corte Del Cedro
- Carlsbad, CA 92011
- United States
Corporate Office
- 6076 Corte Del Cedro
- Carlsbad, CA 92011
- United States
Aomics (Drug Discovery) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 23-Oct-2015 | Completed | Startup |
Aomics (Drug Discovery) Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Bio, Tech and Beyond | Accelerator/Incubator |
Aomics (Drug Discovery) FAQs
-
When was Aomics (Drug Discovery) founded?
Aomics (Drug Discovery) was founded in 2015.
-
Where is Aomics (Drug Discovery) headquartered?
Aomics (Drug Discovery) is headquartered in Carlsbad, CA.
-
What industry is Aomics (Drug Discovery) in?
Aomics (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Aomics (Drug Discovery) a private or public company?
Aomics (Drug Discovery) is a Private company.
-
What is Aomics (Drug Discovery)’s current revenue?
The current revenue for Aomics (Drug Discovery) is
. -
Who are Aomics (Drug Discovery)’s investors?
Bio, Tech and Beyond has invested in Aomics (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »